Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index; 46 of the 80 sources its claims cite were checked for support.

Chronic postsurgical pain: From risk factor identification to multidisciplinary management at the Toronto General Hospital Transitional Pain Service

Open access
Katz, Joel, Weinrib, Aliza Z., Clarke, Hance · 2019 · Canadian Journal of Pain

Abstract

Background: Chronic postsurgical pain is a highly prevalent public health problem associated with substantial emotional, social, and economic costs. Aims: (1) To review the major risk factors for chronic postsurgical pain (CPSP); (2) to describe the implementation of the Transitional Pain Service (TPS) at the Toronto General Hospital, a multiprofessional, multimodal preventive approach to CPSP involving intensive, perioperative psychological, physical, and pharmacological management aimed at preventing and treating the factors that increase the risk of CPSP and related disability; and (3) to present recent empirical evidence for the efficacy of the TPS. Methods: The Toronto General Hospital TPS was specifically developed to target patients at high risk of developing CPSP. The major known risk factors for CPSP are perioperative pain, opioid use, and negative affect, including depression, anxiety, pain catastrophizing, and posttraumatic stress disorder–like symptoms. At-risk patients are identified early and provided comprehensive care by a multidisciplinary team consisting of pain physicians, advanced practice nurses, psychologists, and physical therapists. Results: Preliminary results from two nonrandomized, clinical practice–based trials indicate that TPS treatment is associated with improvements in pain, pain interference, pain catastrophizing, symptoms of anxiety and depression, and opioid use. Almost half of opioid-naïve patients and one in four opioid-experienced patients were opioid free by the 6-month point. Conclusions: These promising results suggest that the TPS benefits patients at risk of CPSP. A multicenter randomized controlled trial of the TPS in several Ontario hospitals is currently underway. © 2019 The Author(s). Published with license by Taylor & Francis Group, LLC.

Overview

CoChat Summary

## TL;DR

This paper reviews chronic postsurgical pain (CPSP) risk factors and describes the Toronto General Hospital Transitional Pain Service (TPS), a multidisciplinary preventive care model for high-risk surgical patients. It also reports preliminary cohort evidence that TPS care is associated with reductions in pain, pain interference, psychological distress, and opioid use.

## Key findings

  • The paper identifies the most consistently reported CPSP risk factors as perioperative pain, opioid use, and negative affect, including depression, anxiety, pain catastrophizing, and posttraumatic stress disorder–like symptoms.
  • In the first TPS cohort study, 382 patients participated; 91 received ACT-based psychology services and 252 did not. By the last TPS visit, both groups improved, but the ACT group showed greater reductions in opioid use and pain interference, and only the ACT group showed a significant reduction in depressed mood.
  • In the opioid-use study, opioid-experienced patients (n = 137) decreased from 78.8 ± 100.2 MME/day pre-surgery to 78.3 ± 113.9 MME/day at about 6 months post-surgery, after peaking at 140.5 ± 124.0 MME/day at hospital discharge; 25% were completely weaned by 6 months.
  • Opioid-naïve high-risk patients (n = 110) decreased from 106.7 ± 80.6 MME/day at hospital discharge to 37.3 ± 61.1 MME/day at about 6 months; 46% were completely weaned by 6 months.

## Methods

  • Narrative review plus description of the TPS program, which was established in 2014 and provides multidisciplinary perioperative care for up to 6 months after surgery.
  • The evidence base summarized here comes from two clinical practice-based cohort studies and one detailed case report; a multicenter randomized controlled trial was noted as ongoing.
  • The cohort analyses compared outcomes between ACT vs no-ACT patients and examined opioid consumption/weaning in opioid-naïve vs opioid-experienced patients using morphine milligram equivalents and repeated measures over the TPS course.

## Limitations

  • The paper explicitly notes that the TPS evidence to date comes from nonrandomized clinical practice-based studies, and that the ACT vs no-ACT groups differed at baseline and in treatment duration; the authors state this raises the question of whether the no-ACT group might have improved further with equal follow-up.
  • The paper states that causality remains unanswered for CPSP risk factors.
  • Evident from the text: the reported TPS findings are preliminary and come from a single-center service experience, so generalizability is limited until the ongoing multicenter randomized trial reports results.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1080/24740527.2019.1574537

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Mean daily opioid use in daily morphine milligram equivalents (MME/day) at the end of TPS treatment shown as a function of daily morphine milligram equivalents at hospital discharge (i.e., prior to TPS treatment) for opioid-naïve and opioid-experienced patients. Also shown is the 90 MME/day maximum dose recommended by the U.S.69 and Canadian70 opioid guidelines (dashed lines). Based on the 90 MME/day, patients in the two lower quadrants (green shading) represent treatment successes and those in the two upper quadrants (red shading) represent treatment failures. Green triangles represent patients who were under 90 MME/day on both occasions and higher at 6 months than at hospital discharge; green circles represent patients who were under 90 MME/day on both occasions and lower at 6 months than at hospital discharge; dark green circles represent patients who were over 90 MME/day at hospital discharge and under at 6 months; cyan stars represent patients who were totally weaned (MME/day = 0) by 6 months; red triangles represent patients who were under 90 MME/day at hospital discharge and over at 6 months; red diamonds represent patients who were over 90 MME/day on both occasions and higher at 6 months than at hospital discharge; blue diamonds represent patients who were over 90 MME/day on both occasions and lower at 6 months than at hospital discharge. Left panel adapted with permission from Clarke et al.65.
Figure 1. Mean daily opioid use in daily morphine milligram equivalents (MME/day) at the end of TPS treatment shown as a function of daily morphine milligram equivalents at hospital discharge (i.e., prior to TPS treatment) for opioid-naïve and opioid-experienced patients. Also shown is the 90 MME/day maximum dose recommended by the U.S.69 and Canadian70 opioid guidelines (dashed lines). Based on the 90 MME/day, patients in the two lower quadrants (green shading) represent treatment successes and those in the two upper quadrants (red shading) represent treatment failures. Green triangles represent patients who were under 90 MME/day on both occasions and higher at 6 months than at hospital discharge; green circles represent patients who were under 90 MME/day on both occasions and lower at 6 months than at hospital discharge; dark green circles represent patients who were over 90 MME/day at hospital discharge and under at 6 months; cyan stars represent patients who were totally weaned (MME/day = 0) by 6 months; red triangles represent patients who were under 90 MME/day at hospital discharge and over at 6 months; red diamonds represent patients who were over 90 MME/day on both occasions and higher at 6 months than at hospital discharge; blue diamonds represent patients who were over 90 MME/day on both occasions and lower at 6 months than at hospital discharge. Left panel adapted with permission from Clarke et al.65.CC BY · PubMed Central
Figure 2. Mean daily opioid use in daily morphine milligram equivalents at hospital discharge shown as a function of daily morphine milligram equivalents preoperatively for opioid-experienced patients. Also shown is the 90 MME/day maximum dose recommended by the U.S. and Canadian opioid guidelines (dashed lines). Legend as in Figure 1.
Figure 2. Mean daily opioid use in daily morphine milligram equivalents at hospital discharge shown as a function of daily morphine milligram equivalents preoperatively for opioid-experienced patients. Also shown is the 90 MME/day maximum dose recommended by the U.S. and Canadian opioid guidelines (dashed lines). Legend as in Figure 1.CC BY · PubMed Central
Figure 3. Pain intensity (0–10 Numeric Rating Scale) and pain interference (0–10 Numeric Rating Scale) scores at hospital discharge and at the end of TPS treatment 6 months later shown for opioid-naïve and opioid-experienced patients. Data from Clarke et al.65. *P < 0.009.
Figure 3. Pain intensity (0–10 Numeric Rating Scale) and pain interference (0–10 Numeric Rating Scale) scores at hospital discharge and at the end of TPS treatment 6 months later shown for opioid-naïve and opioid-experienced patients. Data from Clarke et al.65. *P < 0.009.CC BY · PubMed Central

Verification

Claims the paper makes

32 Valid · 4 Not valid · 13 Not checked · 5 Own results and interpretations

22 more claims · 11 with their cited sources checked

Create a free account to see all 54 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 20
  • Probably not a substantial claim. 8

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 74 references

Research works printed but not linked: 4

  1. Burns LC, 2015, J Pain Res, 15, 21
  2. Katz J, 1997, Proceedings of the 8th world congress on pain, progress in pain research and management, 8, 231
  3. 10.1097/j.pain.0000000000001170 · DOI · Paper page
  4. Gurusamy KS, 2014, Cochrane Database Syst Rev, CD008261

Cited by

See all 87

Metadata

Authors
Katz, J., Weinrib, A. Z., & Clarke, H.
Affiliations
  • University of Toronto (CA)
  • York University (CA)
Corresponding author
Katz, Joel
Venue
Canadian Journal of Pain
Published
2019-07-15
Volume
3
Issue
2
Pages
49-58
ISSN
2474-0527 (ISSN-L)
OpenAlex
W2914004738
Cited by
87
References
74
Citations by year
2026: 9 · 2025: 19 · 2024: 18 · 2023: 17 · 2022: 12 · 2021: 5 · 2020: 3 · 2019: 3
FWCI
1.19
Type
journal article
Language
en
Open access
Locations
  • Canadian Journal of Pain (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • York University
  • Canada Research Chairs
  • Health Canada
  • Canadian Institutes of Health Research
Topics
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pediatric Pain Management Techniques
Keywords
chronic postoperative pain, transitional pain service, risk factors, perioperative pain, opioid use, pain catastrophizing, depression, anxiety, multidisciplinary pain management, pain prevention, Toronto General Hospital

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chronic postsurgical pain: From risk factor identification to multidisciplinary management at the Toronto General Hospital Transitional Pain Service. https://app.cochat.ai/papers/10.1080/24740527.2019.1574537
The paper
Katz, J., Weinrib, A. Z., & Clarke, H. (2019). Chronic postsurgical pain: From risk factor identification to multidisciplinary management at the Toronto General Hospital Transitional Pain Service. Canadian Journal of Pain. https://doi.org/10.1080/24740527.2019.1574537

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.